Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

A&M to Dedicate Key Element of Vaccine Center

September 18, 2014 1:43 am | by The Associated Press | News | Comments

The center is a key part of a $91 million vaccine manufacturing plant at Texas A&M University that proponents hope will create create thousands of jobs while protecting the country against future biological threats and influenza pandemics. 

TOPICS:

Experts Want Restrictions on Testosterone Drug Use

September 17, 2014 6:44 pm | by Matthew Perrone - AP Health Writer - Associated Press | News | Comments

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans currently taking them. The panel of Food and Drug Administration advisers...

TOPICS:

Study: Americans Endure Unwanted Care Near Death

September 17, 2014 3:54 pm | by MATT SEDENSKY, Associated Press | News | Comments

Americans suffer needless discomfort and undergo unwanted and costly care as they die, in part because of a medical system ruled by "perverse incentives" for aggressive care and not enough conversation about what people want, according to a report released Wednesday.

TOPICS:
Advertisement

Study: Artificial Sweeteners May Promote Diabetes

September 17, 2014 3:30 pm | by MALCOLM RITTER, AP Science Writer | News | Comments

Using artificial sweeteners may set the stage for diabetes in some people by hampering the way their bodies handle sugar, suggests a preliminary study done mostly in mice. The authors said they are not recommending any changes in how people use artificial sweeteners based on their study, which included some human experiments.

TOPICS:

Baxter Recalls One Lot of Potassium Chloride Injection

September 17, 2014 3:00 pm | News | Comments

Baxter International Inc. announced today it is voluntarily recalling one lot of Potassium Chloride Injection 10mEq per 100mL, product code 2B0826 to the hospital/pharmacy/nurse level. The recall is being initiated due to a labeling error on the shipping cartons in a single lot, which was identified by three customers.

TOPICS:

Handheld Raman Raw Material Analyzer

September 17, 2014 2:08 pm | by Nikita Ernst, Associate Editor | Product Releases | Comments

Introducing a new handheld Raman analyzer for raw material identification (RMID). 

First UK Volunteer Gets Experimental Ebola Vaccine

September 17, 2014 12:51 pm | by The Associated Press | News | Comments

British scientists say a former nurse has become the first person in the country to receive an experimental Ebola vaccine in an early trial to test its safety. Ruth Atkins, 48, got the injection on Wednesday in Oxford, the first of 60 healthy volunteers in the U.K. who will receive the vaccine.

TOPICS:

Double Diaphragm Pumps

September 17, 2014 12:12 pm | by Nikita Ernst, Associate Editor | Wilden Pump & Engineering, LLC | Product Releases | Comments

Introducing the Advanced™ FIT line of Air-Operated Double-Diaphragm (AODD) Pumps that feature superior flow rates and easy installation.

Advertisement

Continuous Motion Side Seal Wrapper

September 17, 2014 11:41 am | by Nikita Ernst, Associate Editor | Product Releases | Comments

Introducing the new model T2011SSR continuous motion side seal wrapper.

Pre-Engineered Tank For Ultra Pure Applications

September 17, 2014 11:32 am | by Nikita Ernst, Associate Editor | Product Releases | Comments

Introducing a pre-engineered version of the TerraPure tank, molded from FDA-compliant linear polyethylene and available in 125 or 250 gallon capacities.

What's in Your Toothpaste? Some Contain Plastic Microbeads

September 17, 2014 9:11 am | Videos | Comments

A major manufacturer is removing the tiny plastic particles from its toothpaste.                             

TOPICS:

Sun Pharma and Merck Announce $80M Licensing Agreement for Tildrakizumab

September 17, 2014 9:00 am | News | Comments

Merck and Sun Pharmaceutical Industries have announced an exclusive worldwide licensing agreement for Merck’s investigational therapeutic antibody candidate, tildrakizumab, (MK-3222), which is currently being evaluated in Phase 3 registration trials for the treatment of chronic plaque psoriasis.

TOPICS:

Auxilium Pharma Board Adopts Anti-Takeover Plan

September 17, 2014 8:48 am | by The Associated Press | News | Comments

The board of Auxilium Pharmaceuticals has adopted a "poison pill" shareholder rights plan to ward off a hostile takeover after Endo International PLC announced an unsolicited offer worth about $1.41 billion for its fellow drugmaker.   

TOPICS:

Hospitals Struggled During Sandy, Report Says

September 17, 2014 8:43 am | by GEOFF MULVIHILL, Associated Press | News | Comments

When Superstorm Sandy slammed into the Northeast nearly two years ago, hospitals found themselves dealing with surges in patients, lost power supplies and employees who couldn't get to work — problems that a new federal report finds they were not prepared to handle.

TOPICS:

UN: Nearly $1B Needed Now to Stop Ebola

September 17, 2014 8:34 am | by JOHN HEILPRIN, Associated Press; KRISTA LARSON, Associated Press | News | Comments

The number of Ebola cases could start doubling every three weeks in West Africa, the World Health Organization said Tuesday, warning that the outbreak will cost nearly $1 billion to contain so it does not turn into a "human catastrophe."   

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading